Peer review reports
From: Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer
Original Submission |
13 Feb 2023 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
5 Apr 2023 |
Reviewed |
Reviewer Report
|
8 May 2023 |
Reviewed |
Reviewer Report
|
29 May 2023 |
Author responded |
Author comments - Zhengjun Qiu
|
Resubmission - Version 5 |
29 May 2023 |
Submitted |
Manuscript version 5
|
2 Jun 2023 |
Author responded |
Author comments - Zhengjun Qiu
|
Resubmission - Version 6 |
2 Jun 2023 |
Submitted |
Manuscript version 6
|
8 Jun 2023 |
Author responded |
Author comments - Zhengjun Qiu
|
Resubmission - Version 7 |
8 Jun 2023 |
Submitted |
Manuscript version 7
|
25 Jun 2023 |
Author responded |
Author comments - Zhengjun Qiu
|
Resubmission - Version 8 |
25 Jun 2023 |
Submitted |
Manuscript version 8
|
16 Jul 2023 |
Reviewed |
Reviewer Report
|
22 Jul 2023 |
Reviewed |
Reviewer Report
|
Resubmission - Version 9 |
|
Submitted |
Manuscript version 9
|
Publishing |
31 Jul 2023 |
Editorially accepted |
|
23 Aug 2023 |
Article published |
10.1186/s12885-023-11239-w
|
Learn about peer review